Your browser doesn't support javascript.
loading
Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging.
Park, Jaesook; Park, Jin; Ju, Eun Jin; Park, Seok Soon; Choi, Jinhyang; Lee, Jae Hee; Lee, Kyoung Jin; Shin, Seol Hwa; Ko, Eun Jung; Park, Intae; Kim, Chulhee; Hwang, Jung Jin; Lee, Jung Shin; Song, Si Yeol; Jeong, Seong-Yun; Choi, Eun Kyung.
Afiliação
  • Park J; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Park J; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Ju EJ; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Park SS; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Choi J; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Lee JH; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Lee KJ; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Shin SH; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Ko EJ; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Park I; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Kim C; Department of Polymer Science and Engineering, Inha University, Incheon 402-751, South Korea.
  • Hwang JJ; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea; Asan Institute for Life Sciences, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Lee JS; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea; Department of Internal Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.
  • Song SY; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea; Department of Radiation Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea. Electronic address: coocoori@amc.seoul.kr.
  • Jeong SY; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea; Asan Institute for Life Sciences, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea. Electronic address: syj@amc.seoul.kr.
  • Choi EK; Institute for Innovative Cancer Research, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea; Department of Radiation Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea; Center for Development and Commercialization
J Control Release ; 207: 77-85, 2015 Jun 10.
Article em En | MEDLINE | ID: mdl-25863273
ABSTRACT
Hollow gold nanoparticles (HGNP) are a novel class of hybrid metal nanoparticles whose unique optical and morphological properties have spawned new applications including more effective cancer therapy. The shell thickness of HGNPs can tune the surface plasmon resonance to the near infrared light, resulting in photothermal ablation of tumors with optimal light penetration in tissue. The hollow cavity within a HGNP is able to accommodate a high payload of chemotherapeutic agents. They have also been used for enhancing radiosensitization in tumors during radiotherapy due to the high X-ray absorption capability of gold particles. However, no report has yet been published that utilize HGNPs for the triple combination therapy and CT imaging. In this study, we synthesized HGNPs which exhibit better response to radiation for therapy and imaging and demonstrated the effects of combined chemotherapy, thermal and radiotherapy. This combination strategy presented delayed tumor growth by 4.3-fold and reduced tumor's weight by 6.8-fold compared to control tumors. In addition, we demonstrated the feasibility of HGNP as a CT imaging agent. It is expected that translating these capabilities to human cancer patients could dramatically increase the antitumor effect and potentially overcome resistance to chemotherapeutic agents and radiation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Doxorrubicina / Meios de Contraste / Nanopartículas Metálicas / Terapia a Laser / Microtomografia por Raio-X / Quimiorradioterapia / Ouro / Neoplasias Pulmonares / Antibióticos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Doxorrubicina / Meios de Contraste / Nanopartículas Metálicas / Terapia a Laser / Microtomografia por Raio-X / Quimiorradioterapia / Ouro / Neoplasias Pulmonares / Antibióticos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Coréia do Sul